BI-1160.63



Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
dabigatran etexilate
1160.63
NCT00558259
Venous Thromboembolism
Phase 3
 
January 2015